Novavax NVAX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $228.36M-13.3% | $240.63M-54.6% | $268.02M-53.3% | $253.74M-62.7% | $263.34M-45.2% | ||
| $561.97M+20.0% | $494.45M— | $494.87M— | $358.56M— | $468.14M— | ||
| $0-100% | $10.88M+2.4% | $10.82M+2.6% | $10.75M+2.5% | $10.68M+2.2% | ||
| $46.75M+27.0% | $45.56M+7.6% | $42.76M-43.2% | $37.89M-72.2% | $36.82M-75.5% | ||
| $25.71M-63.8% | $26.82M-65.7% | $45.53M-43.1% | $59.82M-41.4% | $71.1M-64.3% | ||
| —— | —— | —— | —— | —— | ||
| $850.82M-2.0% | $978.28M-13.3% | $974.59M-11.7% | $919.51M-23.6% | $868.03M+19.4% | ||
| $42.15M-68.4% | $44.8M-67.6% | $49.12M-82.8% | $129.64M-55.1% | $133.54M-54.1% | ||
| $112.89M+0.8% | $113.46M+5.6% | $113.08M-10.8% | $112.96M-8.4% | $112.03M-9.1% | ||
| $15.95M-27.2% | $17.08M-28.8% | $19.23M-37.1% | $21.39M-36.8% | $21.9M-29.3% | ||
| $1.04B-19.3% | $1.18B-24.6% | $1.18B-31.1% | $1.34B-26.5% | $1.29B-4.5% | ||
| $16.1M-52.9% | $24.58M-40.9% | $15.23M-73.5% | $50.6M-36.7% | $34.16M-40.8% | ||
| $132.45M-6.7% | $137.78M-37.3% | $138.33M-50.9% | $132.53M-45.4% | $142.03M-41.3% | ||
| $88.77M-18.1% | $140.05M-79.3% | $104.25M-83.0% | $113.76M-82.9% | $108.33M-55.0% | ||
| $2.11M-61.4% | $2.51M-64.2% | $5.04M-47.9% | $5.55M-41.1% | $5.48M-12.9% | ||
| —— | —— | —— | —— | —— | ||
| $2.11M-61.4% | $2.51M-64.2% | $5.04M-47.9% | $5.55M-41.1% | $5.48M-12.9% | ||
| —— | —— | —— | —— | —— | ||
| $359.27M-12.3% | $358.94M-19.7% | $397.11M-22.9% | $399.26M-25.2% | $409.56M-51.3% | ||
| $342.46M-18.9% | $459.95M-60.2% | $429.87M-63.6% | $389.14M-66.4% | $422.17M-47.5% | ||
| —— | —— | —— | —— | —— | ||
| $1.91M-96.4% | $2.09M-96.1% | $2.27M-95.8% | $52.37M-4.7% | $53.06M-2.8% | ||
| $193.24M-38.4% | $239.07M-33.5% | $263.48M-17.4% | $287.59M-14.2% | $313.73M-10.8% | ||
| $1.19B-13.2% | $1.3B-40.3% | $1.34B-40.3% | $1.3B-42.3% | $1.37B-38.4% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $1.68M+2.2% | $1.65M+1.9% | $1.65M+2.0% | $1.65M+2.0% | $1.64M+15.9% | ||
| $4.55B+0.8% | $4.54B+0.9% | $4.53B+0.9% | $4.52B+1.0% | $4.51B+7.3% | ||
| -$4.58B-2.0% | -$4.57B+8.8% | -$4.59B+6.9% | -$4.38B+8.8% | -$4.49B+9.6% | ||
| -$5.07M-416% | $2.01M+109% | -$1.75M-148% | -$458K+95.6% | $1.61M+115% | ||
| $112.32M+10.2% | $103.02M+7.5% | $102.66M+8.2% | $102.46M+8.5% | $101.94M+8.5% | ||
| -$144.76M-91.4% | -$127.75M+79.5% | -$156.67M+70.2% | $37.63M+109% | -$75.64M+91.3% | ||
| $1.04B-19.3% | $1.18B-24.6% | $1.18B-31.1% | $1.34B-26.5% | $1.29B-4.5% | ||
| —— | —— | —— | —— | —— | ||
| $561.97M+20.0% | $494.45M— | $494.87M— | $358.56M— | $468.14M— | ||
| $15.95M-27.2% | $17.08M-28.8% | $19.23M-37.1% | $21.39M-36.8% | $21.9M-29.3% | ||
| $21.36M-86.4% | $22.9M-85.8% | $23.87M-85.6% | $153.04M-9.7% | $157.5M-13.1% | ||
| $15.95M-27.2% | $17.08M-28.8% | $19.23M-37.1% | $21.39M-36.8% | $21.9M-29.3% | ||
| $15.95M-27.2% | $17.08M-28.8% | $19.23M-37.1% | $21.39M-36.8% | $21.9M-29.3% | ||
| $359.27M-12.3% | $358.94M-19.7% | $397.11M-22.9% | $399.26M-25.2% | $409.56M-51.3% | ||
| $103.03M-22.0% | $107.17M-49.3% | $115.59M-47.1% | $86.7M-45.5% | $132.17M-48.6% | ||
| $103.03M-22.0% | $107.17M-49.3% | $115.59M-47.1% | $86.7M-45.5% | $132.17M-48.6% | ||
| $132.45M-6.7% | $137.78M-37.3% | $138.33M-50.9% | $132.53M-45.4% | $142.03M-41.3% | ||
| $359.27M-12.3% | $358.94M-19.7% | $397.11M-22.9% | $399.26M-25.2% | $409.56M-51.3% | ||
| $359.27M-12.3% | $358.94M-19.7% | $397.11M-22.9% | $399.26M-25.2% | $409.56M-51.3% | ||
| $295.06M+404% | $280.56M+178% | $7.31M-88.6% | $57.92M-10.1% | $58.53M-3.9% | ||
| $1.68M+2.2% | $1.65M+1.9% | $1.65M+2.0% | $1.65M+2.0% | $1.64M+15.9% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $23.31M-47.6% | $106.45M-1.7% | $34.17M-64.0% | $226.4M+605% | $44.51M+108% | ||
| $2.11M-61.4% | $2.51M-64.2% | $5.04M-47.9% | $5.55M-41.1% | $5.48M-12.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Novavax's total assets?
- Novavax (NVAX) holds $1.0B in total assets, down 19.3% year over year.
- How much debt does Novavax have?
- Novavax carries $295.1M in total debt against -$144.8M of shareholders' equity, a debt-to-equity ratio of 1.54.
- How much cash does Novavax have?
- Novavax holds $228.4M in cash and equivalents.
- Can Novavax cover its short-term obligations?
- Its current ratio is 2.48 — current assets exceed current liabilities.
- Where does Novavax's balance sheet data come from?
- Every line is extracted from Novavax's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
